Clinical Trial Update: Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the value of adding pioglitazone to treatment in chronic myeloid leukemia with BCR-ABL positivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Phase CML

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Mansoura University | Conditions: Chronic Myelogenous Leukemia, BCR-ABL Positive, CML, Chronic Phase | Phase 2 | Status: COMPLETED